Active Ingredient(s):Lenalidomide FDA Approved: * December 27, 2005 Pharm Company: *CELGENE Category:Cancer
Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). For multiple myeloma, it is used after at least one other treatment and generally with dexamethasone. It is taken by mouth.
Common side effects include diarrhea, itchiness, joint pain, fever, headache, and trouble sleeping. Severe side effects include l...
* May have multiple approval dates, manufacturers, or labelers. 3 Discussions